IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately. The £8.7m funding round includes participation from existing...
IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
Medtronic announced CE mark approval and the first commercial European implants for its OmniaSecure system.
The OmniaSecure defibrillation lead connects to an implantable defibrillator. It...
Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Real-world evidence demonstrated the long-term performance and positive...
IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
Medtronic announced CE mark approval and the first commercial European implants for its OmniaSecure system.
The OmniaSecure defibrillation lead connects to an implantable defibrillator. It...
Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled...